- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: DEB-TACE plus Lenvatinib
Total 207 results
-
Peking University Cancer Hospital & InstituteNot yet recruitingHCC | Regorafenib | Transarterial Chemoembolization | Hepatic Arterial Infusion Chemotherapy
-
Guangxi Medical UniversityRecruitingHepatocellular CarcinomaChina
-
Tongji HospitalGeneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)RecruitingCholangiocarcinoma Non-resectableChina
-
Ze-yang Ding, MDGeneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)RecruitingCholangiocarcinoma Non-resectableChina
-
Peking University Cancer Hospital & InstituteNot yet recruiting
-
AstraZenecaRecruitingHepatocellular CarcinomaSpain, Canada, Germany, Belgium, United States, France, Italy, Japan, China, Egypt, India, Russian Federation, Taiwan, Vietnam, Thailand, Saudi Arabia, Portugal, Korea, Republic of, Brazil, Malaysia, Mexico, Philippines, Puerto Rico
-
Peking University Cancer Hospital & InstituteRecruitingAdvanced Hepatocellular Carcinoma (HCC)China
-
Yunfei YuanRecruitingHepatocellular Carcinoma | Transarterial ChemoembolizationChina
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma Non-resectableChina
-
Fudan UniversityRecruiting
-
Air Force Military Medical University, ChinaUnknown
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCarcinoma, HepatocellularItaly
-
Second Affiliated Hospital of Guangzhou Medical...First Affiliated Hospital, Sun Yat-Sen University; First People's Hospital... and other collaboratorsRecruiting
-
Instituto de Investigación Sanitaria de la Fundación...CompletedProspective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCCHepatocellular CarcinomaSpain
-
Surefire Medical, Inc.Terminated
-
Peking Union Medical College HospitalRecruitingHepatocellular CarcinomaChina
-
RenJi HospitalBoston Scientific CorporationNot yet recruiting
-
Gang WuNot yet recruitingCarcinoma, Non-Small Cell Lung
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma Non-resectableChina
-
Wuhan Union Hospital, ChinaRecruiting
-
Fudan UniversityActive, not recruitingHepatocellular CarcinomaChina
-
Johannes Gutenberg University MainzUnknownIntrahepatic Cholangiocellular CarcinomaGermany
-
Johannes Gutenberg University MainzCompleted
-
Translational Research in OncologyBayerRecruitingCarcinoma, HepatocellularKorea, Republic of, United States, Taiwan, Spain, Japan, France, Georgia, Belgium, Germany, Turkey, Italy, Hong Kong, Serbia
-
Second Affiliated Hospital of Guangzhou Medical...Recruiting
-
Sichuan UniversityNot yet recruitingCarrelizumab Plus Lenvatinib Combined With TACE | Borderline Resectable Hepatocellular CarcinomaChina
-
Surefire Medical, Inc.Terminated
-
Xuhua DuanRecruiting
-
Tongji HospitalRecruitingHepatocellular CarcinomaChina
-
Second Affiliated Hospital of Guangzhou Medical...First People's Hospital of Foshan; Huizhou Municipal Central Hospital; Zhongshan... and other collaboratorsCompletedHepatocellular Carcinoma Non-resectableChina
-
Second Affiliated Hospital of Guangzhou Medical...CompletedHepatocellular Carcinoma Non-resectableChina
-
Shanghai Zhongshan HospitalRecruitingA Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCCHepatocellular Carcinoma | DonafenibChina
-
Tianjin Medical University Cancer Institute and...Not yet recruitingObjective Response Rate (ORR)
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.Recruiting
-
University of Texas Southwestern Medical CenterCompletedHepatocellular CancerUnited States
-
Terumo Europe N.V.CompletedHepatocellular CarcinomaBelgium, France
-
Chen XiaopingRecruiting
-
Tongji HospitalRecruitingIntrahepatic CholangiocarcinomaChina
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.RecruitingAdvanced Biliary Tract CancerChina
-
Sun Yat-sen UniversityRecruiting
-
Xinrui ZhuEnrolling by invitationHepatocellular Carcinoma Non-resectable | Tyrosine Kinase Inhibitor | Transarterial Chemoembolization | Immune Checkpoint BlockadeChina
-
AkesoNot yet recruiting
-
Zhejiang Cancer HospitalRecruitingHepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | PharmorubicinChina
-
Tianjin Medical University Cancer Institute and...UnknownHepatocellular Carcinoma Non-resectableChina
-
Andalusian School of Public HealthCompleted
-
IRCCS Centro San Giovanni di Dio FatebenefratelliIRCCS San Raffaele; Fondazione Don Carlo Gnocchi Onlus; IRCCS Centro Neurolesi...Active, not recruiting
-
Ningbo Medical Center Lihuili HospitalRecruiting
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Beijing Tsinghua Chang Gung HospitalRecruitingHepatocellular CarcinomaChina
-
Wen LiRecruitingUnresectable Hepatocellular CarcinomaChina